Cargando…
Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis is a rapidly progressing neurodegenerative disease characterized by the degeneration of motor neurons and loss of various muscular functions. Dyslipidaemia is prevalent in amyotrophic lateral sclerosis with aberrant changes mainly in cholesterol ester and triglyceride....
Autores principales: | Phan, Katherine, He, Ying, Bhatia, Surabhi, Pickford, Russell, McDonald, Gordon, Mazumder, Srestha, Timmins, Hannah C, Hodges, John R, Piguet, Olivier, Dzamko, Nicolas, Halliday, Glenda M, Kiernan, Matthew C, Kim, Woojin Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825811/ https://www.ncbi.nlm.nih.gov/pubmed/36632187 http://dx.doi.org/10.1093/braincomms/fcac340 |
Ejemplares similares
-
The contribution of brain banks to knowledge discovery in amyotrophic lateral sclerosis: A systematic review
por: Mazumder, Srestha, et al.
Publicado: (2022) -
Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
por: Katzeff, Jared S., et al.
Publicado: (2022) -
Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation
por: Katzeff, Jared S., et al.
Publicado: (2020) -
Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia
por: Ahmed, Rebekah M., et al.
Publicado: (2019) -
Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis
por: Mazumder, Srestha, et al.
Publicado: (2022)